SCM
PSTX
Silverarc Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,012,307
| Closed | -$9.72M | – | 82 |
|
|
2024
Q4 | $9.72M | Sell |
1,012,307
-2,675,241
| -73% | -$25.7M | 2.13% | 16 |
|
|
2024
Q3 | $10.5M | Buy |
3,687,548
+79,549
| +2% | +$228K | 2.37% | 14 |
|
|
2024
Q2 | $10.5M | Buy |
3,607,999
+11,523
| +0.3% | +$33.6K | 2.49% | 10 |
|
|
2024
Q1 | $11.5M | Sell |
3,596,476
-109,303
| -3% | -$349K | 3.19% | 11 |
|
|
2023
Q4 | $12.5M | Buy |
3,705,779
+137,794
| +4% | +$463K | 3.71% | 5 |
|
|
2023
Q3 | $8.49M | Buy |
3,567,985
+622,037
| +21% | +$1.48M | 2.57% | 8 |
|
|
2023
Q2 | $5.18M | Buy |
2,945,948
+256,647
| +10% | +$452K | 1.6% | 19 |
|
|
2023
Q1 | $8.28M | Buy |
2,689,301
+459,301
| +21% | +$1.41M | 3.42% | 4 |
|
|
2022
Q4 | $11.8M | Sell |
2,230,000
-324,277
| -13% | -$1.72M | 3.38% | 3 |
|
|
2022
Q3 | $9.02M | Buy |
2,554,277
+2,173,671
| +571% | +$7.67M | 3.05% | 6 |
|
|
2022
Q2 | $982K | Buy |
380,606
+140,910
| +59% | +$364K | 0.3% | 44 |
|
|
2022
Q1 | $1.07K | Buy |
239,696
+4,764
| +2% | +$21 | 0.44% | 49 |
|
|
2021
Q4 | $1.6M | Buy |
+234,932
| New | +$1.6M | 0.65% | 44 |
|